Menu
/REGISTER
PPB
Montecito
Nixon Peabody
Loading...
You are here:  Home  >  Health Care  -  Page 31

Santa Barbara Web Design
Latest

Conejo Valley biotech scene heats up with Sienna IPO

By   /  Friday, July 14th, 2017  /  East Ventura County, Health Care, Latest news, Technology  /  Comments Off on Conejo Valley biotech scene heats up with Sienna IPO

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen’s Kyprolis found to increase cancer survival rate

By   /  Thursday, July 13th, 2017  /  East Ventura County, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen’s Kyprolis found to increase cancer survival rate

A Phase 3 clinical study of Amgen’s multiple myeloma drug Kyprolis showed that it increased overall survival rate when paired with lenalidomide and dexamethasone versus just those two drugs alone. The drug reduced the risk of death by 21 percent, and patients lived 7.9 months longer when on a regimen that included Kyprolis than those Read More →

Read More →
Latest

FDA gives full approval to Amgen leukemia drug Blincyto

By   /  Tuesday, July 11th, 2017  /  East Ventura County, Health Care, Latest news  /  Comments Off on FDA gives full approval to Amgen leukemia drug Blincyto

Amgen’s leukemia drug Blincyto received full approval from the U.S. Food and Drug Administration on July 11 to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia in adults and children. The biotech giant, headquartered in Thousand Oaks, had previously announced that the drug had been fast-tracked for priority review. The full approval includes data Read More →

Read More →
Latest

Sienna Biopharmaceuticals files for $75 million IPO

By   /  Thursday, July 6th, 2017  /  East Ventura County, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Sienna Biopharmaceuticals files for $75 million IPO

Westlake Village biotechnology company Sienna Biopharmaceuticals filed for an initial public offering with the Securities and Exchange Commission on June 3, stating expectations to raise up to $74.75 million. Founded in 2010, the company develops clinical-stage topical therapies for inflammatory skin diseases and other conditions. ARCH Venture Partners and Venvest Capital led a $40 million Read More →

Read More →
Latest

MannKind hires financial adviser after boosting cash on hand

By   /  Thursday, June 29th, 2017  /  East Ventura County, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on MannKind hires financial adviser after boosting cash on hand

MannKind, a Southern California biotechnology company heading to Westlake Village, hired Greenhill & Co. as a financial and strategic adviser June 28, after requesting the last of its line of credit through a loan from the Mann Group. The company will draw on the remaining $30.1 million of funding, using $10.6 million to capitalize unpaid Read More →

Read More →
Latest

MannKind moving to former Kythera space in Westlake Village

By   /  Friday, June 23rd, 2017  /  East Ventura County, Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on MannKind moving to former Kythera space in Westlake Village

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

SerImmune gets $8 million in financing from Illumina Ventures

By   /  Thursday, June 22nd, 2017  /  Health Care, Latest news, Technology, Tri-County Public Companies  /  Comments Off on SerImmune gets $8 million in financing from Illumina Ventures

Santa Barbara immunotherapy and diagnostic company SerImmune received $8 million in financing from San Francisco-based Illumina Ventures to expand its immune mapping platform and database. Illumina invests primarily in early-stage companies researching genomics, life science and health care. A subsidiary of pharmaceutical giant Merck also participated in the financing round, alongside other undisclosed investors. Mapping Read More →

Read More →